Abbreviated New Drug Application. An abbreviated new drug application (ANDA) contains data which is submitted to FDA (Food & Drug Authority) for the review and potential approval of a generic drug product.
Once approved, an applicant may manufacture and market the generic drug product to provide a safe,
effective, lower cost alternative to the brand-name drug it references.